Biodegradable Poly-ε-Caprolactone Scaffolds with ECFCs and iMSCs for Tissue-Engineered Heart Valves.
Georg LutterThomas PuehlerLukas CyganekJette SeilerAnita RoglerTanja HerberthPhilipp KnueppelStanislav N GorbJanarthanan SathananthanStephanie SellersOliver J MüllerDerk FrankIrma HabenPublished in: International journal of molecular sciences (2022)
Clinically used heart valve prostheses, despite their progress, are still associated with limitations. Biodegradable poly-ε-caprolactone (PCL) nanofiber scaffolds, as a matrix, were seeded with human endothelial colony-forming cells (ECFCs) and human induced-pluripotent stem cells-derived MSCs (iMSCs) for the generation of tissue-engineered heart valves. Cell adhesion, proliferation, and distribution, as well as the effects of coating PCL nanofibers, were analyzed by fluorescence microscopy and SEM. Mechanical properties of seeded PCL scaffolds were investigated under uniaxial loading. iPSCs were used to differentiate into iMSCs via mesoderm. The obtained iMSCs exhibited a comparable phenotype and surface marker expression to adult human MSCs and were capable of multilineage differentiation. EFCFs and MSCs showed good adhesion and distribution on PCL fibers, forming a closed cell cover. Coating of the fibers resulted in an increased cell number only at an early time point; from day 7 of colonization, there was no difference between cell numbers on coated and uncoated PCL fibers. The mechanical properties of PCL scaffolds under uniaxial loading were compared with native porcine pulmonary valve leaflets. The Young's modulus and mean elongation at F max of unseeded PCL scaffolds were comparable to those of native leaflets ( p = ns.). Colonization of PCL scaffolds with human ECFCs or iMSCs did not alter these properties ( p = ns.). However, the native heart valves exhibited a maximum tensile stress at a force of 1.2 ± 0.5 N, whereas it was lower in the unseeded PCL scaffolds (0.6 ± 0.0 N, p < 0.05). A closed cell layer on PCL tissues did not change the values of F max (ECFCs: 0.6 ± 0.1 N; iMSCs: 0.7 ± 0.1 N). Here, a successful two-phase protocol, based on the timed use of differentiation factors for efficient differentiation of human iPSCs into iMSCs, was developed. Furthermore, we demonstrated the successful colonization of a biodegradable PCL nanofiber matrix with human ECFCs and iMSCs suitable for the generation of tissue-engineered heart valves. A closed cell cover was already evident after 14 days for ECFCs and 21 days for MSCs. The PCL tissue did not show major mechanical differences compared to native heart valves, which was not altered by short-term surface colonization with human cells in the absence of an extracellular matrix.
Keyphrases
- induced pluripotent stem cells
- endothelial cells
- aortic valve
- tissue engineering
- single cell
- heart failure
- mesenchymal stem cells
- pluripotent stem cells
- cell therapy
- drug delivery
- randomized controlled trial
- gene expression
- extracellular matrix
- poor prognosis
- pulmonary hypertension
- high resolution
- cell death
- bone marrow
- induced apoptosis
- aortic valve replacement
- mitral valve
- cell proliferation
- umbilical cord
- heat stress
- atomic force microscopy
- aortic stenosis